fbpx
close read more

The Servier Group

Committed to therapeutic progress to serve patient needs

Meet the healthcare challenges of tomorrow

Committed employees

Men and women proud to contribute to care for patients and save lives

Join our Group

Servier R&D

Meeting patient needs as effectively as possible

Accelerate therapeutic innovation

A local production

The agility of an integrated industrial model

Industrial excellence for a quality healthcare offering

Servier - Independent international pharmaceutical laboratory

logo twitter
22500

employees, including  4,900 in France.

150
countries in which
the Group’s medicines
are distributed
23 %

of revenue from brand-name medicines invested in R&D in 2019/2020.

4.7 billion

euros in revenue in 2019/2020 comprising €3.3 billion for brand-name medicines and €1.4 billion for generic medicines.

4 therapeutic areas

oncology,
cardiometabolism, neurosciences
and immuno-inflammation

icon play
icon play

Join our teams!


We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.

Counterfeit medicines: a global threat

Servier has long been committed to combating counterfeit medicines and is now working harder than ever against this threat exacerbated by the health emergency created by the Covid-19.

#BecauseIsayso


In collaboration with the International Society of Hypertension, Servier is launching a a new edition of “#BecauseIsayso #CheckYourPressure” a worldwide public awareness campaign of the importance of blood pressure measurement.

The basis for our actions

Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.

icon play